Albumin Stimulates Interleukin-8 Expression in Proximal Tubular Epithelial Cells in Vitro and in Vivo
Overview
Authors
Affiliations
Renal tubulointerstitial injury is characterized by inflammatory cell infiltrate; however, the stimuli for leukocyte recruitment are not fully understood. IL-8 is a potent chemokine produced by proximal tubular epithelial cells (PTECs). Whether nephrotic proteins stimulate tubular IL-8 expression remains unknown. Acute exposure of human PTECs to albumin induced IL-8 gene and protein expression time- and dose-dependently. Apical albumin predominantly stimulated basolateral IL-8 secretion. Electrophoretic mobility shift assay demonstrated nuclear translocation of NF-kappaB, and the p65/p50 subunits were activated. NF-kappaB activation and IL-8 secretion were attenuated by the NF-kappaB inhibitors pyrrolidine dithiocarbamate and cell-permeable peptide. Albumin upregulated intracellular reactive oxygen species (ROS) generation, while exogenous H2O2 stimulated NF-kappaB translocation and IL-8 secretion. Albumin-induced ROS generation, NF-kappaB activation, and IL-8 secretion were endocytosis- and PKC-dependent as these downstream events were abrogated by the PI3K inhibitors LY294002 and wortmannin, and the PKC inhibitors GF109203X and staurosporin, respectively. In vivo, IL-8 mRNA expression was localized by in situ hybridization to the proximal tubules in nephrotic kidney tissues. The intensity of IL-8 immunostaining was higher in nephrotic than non-nephrotic subjects. In conclusion, albumin is a strong stimulus for tubular IL-8 expression, which occurs via NF-kappaB-dependent pathways through PKC activation and ROS generation.
Sanagawa A, Takase H Basic Clin Pharmacol Toxicol. 2025; 136(4):e70015.
PMID: 40018909 PMC: 11869354. DOI: 10.1111/bcpt.70015.
Rahayu I, Arfian N, Kustanti C, Wahyuningsih M Bioimpacts. 2025; 15:30129.
PMID: 39963561 PMC: 11830129. DOI: 10.34172/bi.30129.
Bottussi A, Ursoleo J, Agosta V, De Luca M, Monaco F Future Cardiol. 2025; 21(3):191-202.
PMID: 39921856 PMC: 11875465. DOI: 10.1080/14796678.2025.2463271.
Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy.
Antoniadou C, Gavriilidis E, Ritis K, Tsilingiris D Metabol Open. 2025; 25:100344.
PMID: 39886103 PMC: 11780985. DOI: 10.1016/j.metop.2024.100344.
Tubulointerstitial injury in proteinuric chronic kidney diseases.
Cortinovis M, Perico N, Remuzzi G Front Med (Lausanne). 2024; 11:1478697.
PMID: 39529801 PMC: 11550959. DOI: 10.3389/fmed.2024.1478697.